Abstract
Hydrogen peroxide (H2O2) can be detected in freshly-voided human urine from healthy subjects and has been proposed as a “biomarker” of oxidative stress. This paper summarizes our studies to examine the extent to which urinary H2O2 measurement fulfils the criteria for the “ideal biomarker”. Levels of H2O2, standardised for creatinine, varied widely between subjects. In most subjects, levels also varied considerably when measurements were made at different times and on different days. A reproducible increase in urinary H2O2 was detected in all subjects examined after drinking coffee, a beverage rich in H2O2. By contrast, green tea decreased urinary H2O2 levels. We conclude that the H2O2 in coffee is not excreted into urine. Instead, hydroxyhydroquinone from coffee is absorbed, excreted and oxidises in urine to produce H2O2. No other confounders of urinary H2O2 have been identified to date. Work is underway to compare H2O2 levels with variations in other biomarkers of oxidative damage, to test the possibility that there are daily or other periodic variations in oxidative damage rates.
Keywords: urine, hydrogen peroxide, oxidative damage, coffee, superoxide, flavonoid, hydroxyhydroquinone, ascorbate
Current Medicinal Chemistry
Title: Establishing Biomarkers of Oxidative Stress: The Measurement of Hydrogen Peroxide in Human Urine
Volume: 11 Issue: 9
Author(s): Barry Halliwell, Lee Hua Long, Tsin Pinn Yee, Sharon Lim and Ronan Kelly
Affiliation:
Keywords: urine, hydrogen peroxide, oxidative damage, coffee, superoxide, flavonoid, hydroxyhydroquinone, ascorbate
Abstract: Hydrogen peroxide (H2O2) can be detected in freshly-voided human urine from healthy subjects and has been proposed as a “biomarker” of oxidative stress. This paper summarizes our studies to examine the extent to which urinary H2O2 measurement fulfils the criteria for the “ideal biomarker”. Levels of H2O2, standardised for creatinine, varied widely between subjects. In most subjects, levels also varied considerably when measurements were made at different times and on different days. A reproducible increase in urinary H2O2 was detected in all subjects examined after drinking coffee, a beverage rich in H2O2. By contrast, green tea decreased urinary H2O2 levels. We conclude that the H2O2 in coffee is not excreted into urine. Instead, hydroxyhydroquinone from coffee is absorbed, excreted and oxidises in urine to produce H2O2. No other confounders of urinary H2O2 have been identified to date. Work is underway to compare H2O2 levels with variations in other biomarkers of oxidative damage, to test the possibility that there are daily or other periodic variations in oxidative damage rates.
Export Options
About this article
Cite this article as:
Halliwell Barry, Long Hua Lee, Yee Pinn Tsin, Lim Sharon and Kelly Ronan, Establishing Biomarkers of Oxidative Stress: The Measurement of Hydrogen Peroxide in Human Urine, Current Medicinal Chemistry 2004; 11 (9) . https://dx.doi.org/10.2174/0929867043365404
DOI https://dx.doi.org/10.2174/0929867043365404 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alcohol and the Cardiovascular System: A Double-Edged Sword
Current Pharmaceutical Design Drug Disposition in Pathophysiological Conditions
Current Drug Metabolism Myogenic Properties of Brain and Cardiac Vessels and their Relation to Disease
Current Vascular Pharmacology Conivaptan: Potential Therapeutic Implications in Heart Failure
Recent Patents on Cardiovascular Drug Discovery Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design Vascular Remodelling in Well-controlled Hypertensive Patients: The Challenge of Residual Risk Management
Current Pharmaceutical Design Compritol<sup>®</sup>888 ATO a Lipid Excipient for Sustained Release of Highly Water Soluble Active: Formulation, Scale-up and IVIVC Study
Current Drug Delivery A Review of Dietary Influences on Cardiovascular Health: Part 1: the role of Dietary Nutrients
Cardiovascular & Hematological Disorders-Drug Targets Individual Differences in the Neurobiology of Social Stress: Implications for Depression-Cardiovascular Disease Comorbidity
Current Neuropharmacology Flaxseed for Health and Disease: Review of Clinical Trials
Combinatorial Chemistry & High Throughput Screening microRNAs-based Predictor Factor in Patients with Migraine-ischemic Stroke
MicroRNA Free Fatty Acids: Circulating Contributors of Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Subpopulations of Bone Marrow Mesenchymal Stem Cells Exhibit Differential Effects in Delaying Retinal Degeneration
Current Molecular Medicine Inflammation in Cardiovascular Disease and Regulation of the Actin Cytoskeleton in Inflammatory Cells: The Actin Cytoskeleton as a Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Studies on the Effect of the Apolipoprotein E Genotype on the Lipid Profile in Alzheimers Disease
Current Alzheimer Research Pharmacological Properties of Indazole Derivatives: Recent Developments
Mini-Reviews in Medicinal Chemistry Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]
Current Pharmaceutical Design New Insight into Urate-Related Mechanism of Cardiovascular Damage
Current Pharmaceutical Design Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome
Current Pharmacogenomics and Personalized Medicine Mechanism Underlying the Formation of a Cluster of Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets